Skip to content

Aspiration of Excessive Endometrial Fluid at the Day of Ovum Retrieval Plus Diosmin in (ICSI) Cycles

Aspiration of Excessive Endometrial Fluid at the Day of Ovum Retrieval Plus Diosmin in (ICSI) Cycles

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02158000
Enrollment
200
Registered
2014-06-06
Start date
2014-06-30
Completion date
2021-11-30
Last updated
2022-06-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Brief summary

To notify the effect of aspiration of excessive endometrial fluid in addition to Diosmin in cases undergoing intracytoplasmic sperm injection (ICSI) cycles.

Detailed description

Objectives: To notify the effect of aspiration of excessive endometrial fluid in addition to Diosmin in cases undergoing intracytoplasmic sperm injection (ICSI) cycles. Study design: Prospective randomized controlled clinical trial. Patients and Methods: 200 women with excessive endometrial fluid by transvaginal ultrasound during ICSI cycles are randomly scheduled into two equal groups. In group A, one tab every 8 hs Diosmin ( 500mg) beginning from the day of ovum retrieval in addition to aspiration of the fluid by an IUI catheter ; while in group B (control group), no thing is given or done. The main outcome measures are presence of the fluid on the day of embryo transfer and the pregnancy rate on those patients.

Interventions

OTHERgroup A

one tab every 8 hs Diosmin ( 500mg) beginning from the day of ovum retrieval in addition to aspiration of the fluid by an IUI catheter

Sponsors

Benha University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
23 Years to 48 Years
Healthy volunteers
No

Inclusion criteria

* women with excessive endometrial fluid by transvaginal ultrasound during ICSI cycles

Exclusion criteria

* none

Design outcomes

Primary

MeasureTime frameDescription
the pregnancy rateis checked 16 days after embryos transferis assessed by :serum hCG test Beta sub-unit of hCG (serum hCG test)

Secondary

MeasureTime frameDescription
presence of the fluid on the day of embryo transferat the day of embryo transferdetection of excessive endometrial fluid by transvaginal ultrasound during ICSI cycles

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026